Wall Street Zen Downgrades HealthEquity to 'Hold'

Analysts cite concerns over the company's future performance

Mar. 28, 2026 at 5:18am

Got story updates? Submit your updates here. ›

Investment firm Wall Street Zen has downgraded HealthEquity (NASDAQ:HQY) from a 'buy' rating to a 'hold' rating in a research note published on Saturday. The move comes as analysts express uncertainty about the company's outlook and growth prospects.

Why it matters

HealthEquity is a leading provider of consumer-directed healthcare accounts and related services, so this rating change could signal broader concerns about the company's ability to maintain its strong performance in the face of market challenges.

The details

In the research note, Wall Street Zen cited a number of factors that led to the downgrade, including increased competition in the consumer-directed healthcare space and potential headwinds facing the company's core business. The analysts also noted that HealthEquity's stock price has underperformed the broader market in recent months.

  • The research note was published on Saturday, March 28, 2026.

The players

Wall Street Zen

An investment research firm that provides analysis and ratings on publicly traded companies.

HealthEquity

A leading provider of consumer-directed healthcare accounts and related services, headquartered in Draper, Utah.

Got photos? Submit your photos here. ›

What’s next

Investors will be closely watching HealthEquity's upcoming earnings report and any further guidance from the company on its growth strategy and outlook.

The takeaway

This rating downgrade highlights the challenges facing HealthEquity as it navigates a rapidly evolving consumer-directed healthcare market. The company will need to demonstrate its ability to adapt and maintain its competitive edge in order to regain investor confidence.